Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001641172-25-025721·Avalo Therapeutics, Inc.
Schedule 13G ownership disclosure
Avalo Therapeutics, Inc.
Common Stock, $0.001 Par Value · CUSIP: 05338F306
Event date: 2025-08-06
- Filing-level shares
- 549,467.00
- Percent of class
- 4.2%
- Patrick J. Crutcher
Shares: 549,467.00 · Class: 4.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-025721
- Form type
- SCHEDULE 13G/A
- Filer
- Avalo Therapeutics, Inc.
- CIK
- CIK 1534120
- Filed
- Aug 27, 2025
- Reporting period
- Aug 06, 2025
- Description
- Schedule 13G beneficial ownership